1) Strategy & Leadership
- IFF is focusing on transforming its portfolio by divesting the Food Ingredients business, which is valued at approximately $4.3 billion.
- The divestiture aims to sharpen IFF's focus on higher growth and higher-margin segments: Taste, Scent, and Health & Biosciences.
- The company plans to eliminate about two-thirds of the $100 million in stranded costs associated with the divestiture within the first year, with the remainder in the second year.
- IFF is committed to enhancing its R&D capabilities, increasing spending from 7% to 9% of sales, to maintain competitiveness against rising Chinese competition.

2) Financial & Segment Results
- For Q2 2026, IFF reported revenue of nearly $2 billion, reflecting a 6% increase driven by volume growth across all segments.
- Adjusted operating EBITDA rose 6% to $408 million, with notable contributions from all business segments:
| Segment | Q2 Sales ($M) | YoY Growth (%) | EBITDA ($M) | EBITDA Growth (%) | |-----------------------|----------------|----------------|-------------|-------------------| | Taste | 688 | 4 | 124 | 6 | | Health & Biosciences | 601 | 5 | 150 | 6 | | Scent | 665 | 8 | 134 | 5 |
- Free cash flow for the first half of 2026 totaled $378 million, up $284 million YoY, attributed to improved net working capital management.

3) Problems / Headwinds
- The ongoing conflict in the Middle East is creating uncertainty, impacting the Fine Fragrance segment, which saw only low single-digit growth despite previous expectations for higher performance.
- Stranded costs from the Food Ingredients divestiture are temporarily pressuring margins in the remaining segments.
- IFF anticipates working capital headwinds in the second half of 2026 due to the separation of the Food Ingredients business, which may affect cash flow.

4) Operational or Product Plans
- IFF is executing a remediation plan to address stranded costs, focusing on process redesign and rationalizing activities to enhance profitability.
- The company is prioritizing high-return growth opportunities within its core segments, aiming for sustained revenue and EBITDA growth.
- IFF plans to allocate over $1 billion from the Food Ingredients divestiture to reduce debt and initiate a $2.5 billion share repurchase program, with $500 million expected to be executed in the second half of 2026.

5) Guidance & Outlook / Investor Angle
- IFF has raised its full-year 2026 guidance, now expecting sales between $7.4 billion and $7.6 billion, and EBITDA between $1.53 billion and $1.6 billion, reflecting a more favorable outlook post-divestiture.
- The company expects to navigate macroeconomic pressures effectively, with a focus on organic growth and productivity improvements.
- There is confidence in achieving a net debt to EBITDA ratio between 2.0x and 2.5x by the end of 2027, significantly improved from 4.5x at the beginning of 2024.

Bottom line: IFF's strategic divestiture of the Food Ingredients business is set to enhance its focus on high-margin segments, improve profitability, and strengthen its balance sheet, positioning the company for sustainable growth despite current market uncertainties.